Holen Sie sich die Stockscreener-App
0.7464
1.55%
0.0114
Schlusskurs vom Vortag:
$0.735
Offen:
$0.75
24-Stunden-Volumen:
29,397
Relative Volume:
0.10
Marktkapitalisierung:
$94.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.78M
KGV:
-1.3329
EPS:
-0.56
Netto-Cashflow:
$-61.27M
1W Leistung:
-0.31%
1M Leistung:
+7.38%
6M Leistung:
-62.68%
1J Leistung:
-73.34%
1-Tages-Spanne:
$0.7402
$0.7601
1-Wochen-Bereich:
$0.71
$0.772
52-Wochen-Spanne:
$0.66
$3.09
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Vergleichen Sie NAUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.7463 | 90.83M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.50 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.58 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.94 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
569.93 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.32 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Eingeleitet | Goldman | Neutral |
| 2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
What analysts say about Nautilus Biotechnology Inc. stockMarket-beating performance - jammulinksnews.com
Is Nautilus Biotechnology Inc. a good long term investmentExponential return rates - Autocar Professional
What makes Nautilus Biotechnology Inc. stock price move sharplyProfessional Stock Screener - Newser
What drives Nautilus Biotechnology Inc. stock priceFree Capital Growth Strategies - jammulinksnews.com
How Nautilus Biotechnology Inc. stock performs during market volatilityWeekly Big Movers - Newser
Nautilus Biotechnology Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025 - 富途牛牛
What analysts say about Digital Ally Inc. stockSuperior risk-adjusted returns - Jammu Links News
Best Stocks for Conservative Investors in India Expert Long Term StocksExplosive capital appreciation - Jammu Links News
Macro Trends and Their Impact on Visaka Industries Limited (509055)Tremendous wealth creation - Jammu Links News
What makes Stagwell Inc. stock price move sharplyHigh Reward Swing Trades - Newser
Why HLXCP stock attracts strong analyst attentionOptimized Return Investment Picks - Newser
Why TSHA stock attracts strong analyst attentionWeekly Big Movers - Newser
Why Nautilus Biotechnology Inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser
Why Veris Residential Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser
Nautilus Biotechnology's Q2 2025: Can Proteomics Innovation Drive the Next Phase of Growth? - AInvest
Nautilus Biotechnology, Inc. to Report Second Quarter 2025 Financial Results and Host Webcast Conference Call - Nasdaq
What makes L.B. Foster Company stock price move sharplyDaily Swing Candidates - Newser
How ARAY stock performs during market volatilityFree Access to Community - Newser
Why GGAL stock attracts strong analyst attentionRisk Aware High Growth Picks - Newser
hpepe(hero pepe) price forecastProven Win Setups - Newser
Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 7.5% – Should You Sell? - Defense World
The Next Generation of Proteome Analysis - the-scientist.com
Insiders of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) have had a great week after last week's US$12m gain and they haven't stopped buying - Yahoo Finance
EDGE(dadi) Price TodaySecure Your Capital Strategy - newser.com
Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLC - Defense World
Home Product Center Public (OTCMKTS:HPCRF) Trading Up 20.5% – Should You Buy? - Defense World
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Bought by Jane Street Group LLC - Defense World
Citadel Advisors LLC Raises Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer - Business Wire
Northern Trust Corp Sells 32,695 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nautilus Biotechnology Inc-Aktie (NAUT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
4.56%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):